NCT05234333View on ClinicalTrials.gov

COVID-19 Vaccines Associated Malaise

CompletedOBSERVATIONAL
Enrollment

1,534,706

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

January 26, 2022

Study Completion Date

January 26, 2022

Conditions
Vaccine Adverse Reaction
Interventions
DRUG

SARS-CoV-2 vaccine

SARS-CoV-2 vaccination

Trial Locations (1)

14033

Caen University Hospital, Department of Pharmacology, Caen

All Listed Sponsors
lead

University Hospital, Caen

OTHER

NCT05234333 - COVID-19 Vaccines Associated Malaise | Biotech Hunter | Biotech Hunter